3B Blackbio Dx Statistics

Total Valuation

3B Blackbio Dx has a market cap or net worth of INR 10.34 billion. The enterprise value is 10.17 billion.

Market Cap	10.34B
Enterprise Value	10.17B

Important Dates

The next estimated earnings date is Tuesday, May 26, 2026.

Earnings Date	May 26, 2026
Ex-Dividend Date	Sep 19, 2025

Share Statistics

3B Blackbio Dx has 8.57 million shares outstanding. The number of shares has increased by 1.69% in one year.

Current Share Class	8.57M
Shares Outstanding	8.57M
Shares Change (YoY)	+1.69%
Shares Change (QoQ)	-1.03%
Owned by Insiders (%)	47.56%
Owned by Institutions (%)	3.82%
Float	2.78M

Valuation Ratios

The trailing PE ratio is 17.83.

PE Ratio	17.83
Forward PE	n/a
PS Ratio	8.02
PB Ratio	3.40
P/TBV Ratio	3.47
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	17.70
EV / Sales	7.89
EV / EBITDA	18.12
EV / EBIT	18.48
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.00
Debt / EBITDA	0.00
Debt / FCF	n/a
Interest Coverage	311.43

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	15.19%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	6.03%
Revenue Per Employee	15.17M
Profits Per Employee	6.76M
Employee Count	85
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, 3B Blackbio Dx has paid 167.02 million in taxes.

Income Tax	167.02M
Effective Tax Rate	22.31%

Stock Price Statistics

The stock price has decreased by -30.53% in the last 52 weeks. The beta is 0.32, so 3B Blackbio Dx's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	-30.53%
50-Day Moving Average	1,529.69
200-Day Moving Average	1,473.44
Relative Strength Index (RSI)	30.23
Average Volume (20 Days)	11,089

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, 3B Blackbio Dx had revenue of INR 1.29 billion and earned 574.68 million in profits. Earnings per share was 67.66.

Revenue	1.29B
Gross Profit	926.03M
Operating Income	550.30M
Pretax Income	748.62M
Net Income	574.68M
EBITDA	561.38M
EBIT	550.30M
Earnings Per Share (EPS)	67.66

Full Income Statement

Balance Sheet

The company has 227.67 million in cash and 2.62 million in debt, giving a net cash position of 225.05 million or 26.27 per share.

Cash & Cash Equivalents	227.67M
Total Debt	2.62M
Net Cash	225.05M
Net Cash Per Share	26.27
Equity (Book Value)	3.04B
Book Value Per Share	355.75
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 71.80%, with operating and profit margins of 42.67% and 44.56%.

Gross Margin	71.80%
Operating Margin	42.67%
Pretax Margin	58.04%
Profit Margin	44.56%
EBITDA Margin	43.52%
EBIT Margin	42.67%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 0.32%.

Dividend Per Share	4.00
Dividend Yield	0.32%
Dividend Growth (YoY)	33.33%
Years of Dividend Growth	2
Payout Ratio	n/a
Buyback Yield	-1.69%
Shareholder Yield	-1.37%
Earnings Yield	5.56%
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1